BR9507086A - Treatment of diabetic nephrotherapy with valsartan - Google Patents

Treatment of diabetic nephrotherapy with valsartan

Info

Publication number
BR9507086A
BR9507086A BR9507086A BR9507086A BR9507086A BR 9507086 A BR9507086 A BR 9507086A BR 9507086 A BR9507086 A BR 9507086A BR 9507086 A BR9507086 A BR 9507086A BR 9507086 A BR9507086 A BR 9507086A
Authority
BR
Brazil
Prior art keywords
nephrotherapy
valsartan
diabetic
treatment
diabetic nephrotherapy
Prior art date
Application number
BR9507086A
Other languages
Portuguese (pt)
Inventor
Marc De Gasparo
Nigel Levens
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4195481&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9507086(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of BR9507086A publication Critical patent/BR9507086A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9507086A 1994-03-17 1995-03-07 Treatment of diabetic nephrotherapy with valsartan BR9507086A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH80094 1994-03-17
PCT/EP1995/000831 WO1995024901A1 (en) 1994-03-17 1995-03-07 Treatment of diabetic nephropathy with valsartan

Publications (1)

Publication Number Publication Date
BR9507086A true BR9507086A (en) 1997-09-16

Family

ID=4195481

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9507086A BR9507086A (en) 1994-03-17 1995-03-07 Treatment of diabetic nephrotherapy with valsartan

Country Status (12)

Country Link
EP (1) EP0750500A1 (en)
JP (1) JPH09510225A (en)
CN (1) CN1143908A (en)
AU (1) AU1850695A (en)
BR (1) BR9507086A (en)
CA (1) CA2184712A1 (en)
CZ (1) CZ268896A3 (en)
FI (1) FI963611A (en)
HU (1) HUT76542A (en)
PL (1) PL316259A1 (en)
SK (1) SK117996A3 (en)
WO (1) WO1995024901A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT883401E (en) * 1996-02-29 2003-03-31 Novartis Ag AT1 RECEPTOR ANTAGONIST FOR APOPTOSIS STIMULATION
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
AU8996698A (en) * 1997-09-10 1999-03-29 Ono Pharmaceutical Co. Ltd. Peroxisome proliferator-activated receptor controllers
ES2552639T3 (en) * 1998-07-10 2015-12-01 Novartis Pharma Ag Combined use of valsartan and calcium channel blockers for therapeutic purposes
CZ293257B6 (en) * 1998-12-23 2004-03-17 Novartis Ag Pharmaceutical preparation containing AT-1 receptor antagonist for treating diseases associated with an increase of AT-1 in the sub-epithelial area
US6465502B1 (en) * 1998-12-23 2002-10-15 Novartis Ag Additional therapeutic use
EP1296677A2 (en) * 2000-06-22 2003-04-02 Novartis AG Solid valsartan pharmaceutical compositions
HU229280B1 (en) 2000-07-19 2013-10-28 Novartis Ag Valsartan salts
PE20020617A1 (en) * 2000-08-22 2002-08-05 Novartis Ag COMPOSITION INCLUDING AN AT1 RECEPTOR ANTAGONIST AND AN INSULIN SECRETION POTENTIAL OR AN INSULIN SENSITIZER
US20060089389A1 (en) 2000-08-22 2006-04-27 Malcolm Allison Combination
EG24716A (en) 2002-05-17 2010-06-07 Novartis Ag Combination of organic compounds
EP1454625A1 (en) * 2003-03-06 2004-09-08 Speedel Development AG Pyridylsulfonamidyl-pyrimidines for the treatment of diabetic nephropathies
AU2004289057A1 (en) * 2003-11-14 2005-05-26 Novartis Ag AT1-receptor antagonists for treating nephrotic syndrome
TR200703568A1 (en) 2007-05-24 2008-07-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Valsartan formulations
EP2405899A2 (en) 2009-03-11 2012-01-18 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Valsartan formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026402A1 (en) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Non-steroidal antiinflammatory agents - for treatment of micro:vascular disease, e.g. diabetic retinopathy or diabetic nephropathy
DE122007000050I1 (en) * 1990-02-19 2007-11-08 Novartis Ag acyl compounds
US5140037A (en) * 1990-03-20 1992-08-18 E. I. Du Pont De Nemours And Company Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists
GB9027210D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
IL104755A0 (en) * 1992-02-17 1993-06-10 Ciba Geigy Ag Treatment of glaucoma

Also Published As

Publication number Publication date
EP0750500A1 (en) 1997-01-02
AU1850695A (en) 1995-10-03
CZ268896A3 (en) 1997-03-12
MX9603999A (en) 1997-12-31
CN1143908A (en) 1997-02-26
HUT76542A (en) 1997-09-29
CA2184712A1 (en) 1995-09-21
SK117996A3 (en) 1997-03-05
PL316259A1 (en) 1997-01-06
FI963611A0 (en) 1996-09-13
JPH09510225A (en) 1997-10-14
HU9602536D0 (en) 1996-11-28
WO1995024901A1 (en) 1995-09-21
FI963611A (en) 1996-09-13

Similar Documents

Publication Publication Date Title
LV11615A (en) Amid with medical treatment
NO976063D0 (en) Procedure for the treatment of diabetes
BR9612293A (en) Non-invasive blood analyzer
DE69524138D1 (en) Skin treatment agents
DE69626993D1 (en) WOUND TREATMENT COMPOSITION
BR9507086A (en) Treatment of diabetic nephrotherapy with valsartan
FI973216A (en) Treatment of diabetic neuropathy
BR9606298A (en) Transgenic fish in the treatment of diabetes
NO975718L (en) Treatment of insulin resistance
FI955182A0 (en) Body structure
BR9503004A (en) Syringe set
BR9610382A (en) Cableo treatment composition
ATE397073T1 (en) HUMAN DNASE I VARIANTS
DK56293D0 (en) SOEMODS DIABETIC BOLKS
ZA989514B (en) Treatment of diabetic retinopathy
KR960009975U (en) Disposable bandages
DK48194A (en) Medical electrode
DK0734514T3 (en) Tissue sample treatment
NO963869D0 (en) Treatment of diabetic nephropathy with valsartan
KR960033579U (en) Diabetes treatment
KR950026706U (en) Treatment fever
DE19680740T1 (en) Fiber treatment composition
GB9618290D0 (en) Treatment of diabetes
FI693U1 (en) Blus Foer saengliggande patient
LV10524A (en) Gazes turbodzine

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal